{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7199903","sourcedb":"PMC","sourceid":"7199903","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7199903","text":"We note the dispersion of oligomannose-type glycans across both the S1 and S2 subunits. This is in contrast to other viral glycoproteins; for example, the dense glycan clusters in several strains of HIV-1 Env induce oligomannose-type glycans that are recognized by antibodies (32, 33). In SARS-CoV-2 S, the oligomannose-type structures are likely protected by the protein component, as exemplified by the N234 glycan, which is partially sandwiched between the N-terminal and receptor binding domains (Fig. 3).","typesettings":[{"style":"italic","span":{"begin":277,"end":279}},{"style":"italic","span":{"begin":281,"end":283}}],"project":"LitCovid-sample-PD-HP"}